Kerry Wentworth
CHIEF REGULATORY OFFICER · Nuvation Bio Inc.
- 2026
- Jun 24, 2026
- 4
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Kerry Wentworth files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Gary Hattersley - $3.88M in NUVB purchases and sales in the last 12 months
- Dongfang Liu - $1.87M in NUVB purchases and sales in the last 12 months
- David C. Hanley - $1.43M in NUVB purchases and sales in the last 12 months
- Stacy Markel - $753K in NUVB purchases and sales in the last 12 months
- Philippe Sauvage - $286K in NUVB purchases and sales in the last 12 months
- Robert Mashal - $118K in NUVB purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Kerry Wentworth?
Kerry Wentworth is a corporate insider, tracked as CHIEF REGULATORY OFFICER of Nuvation Bio Inc. (NUVB). InsiderAlpha holds 4 primary Form 4 filings for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did Kerry Wentworth last file a Form 4?
The most recent primary Form 4 on record is dated 24 June 2026, one of 4 filings going back to 2026.
Has Kerry Wentworth been buying or selling stock?
Recorded transactions: 0 open-market purchases and 3 open-market sales ($1.47M) across all tracked filings.
